Shares in Cochlear soared after a weaker Australian dollar helped the bionic ear company lift half year profit by 32% to $94.03 million.
A short time ago, the shares broke through the $100 each level, rising 10.05% to $100.34.
It’s one of two on the ASX to be worth more than $100. The other is vitamin maker Blackmores, currently trading at $168.69.
Cochlear sales revenue would have risen only 16% without that boost from currency.
The company pushed sales revenue to $581.72 million, a rise of 32%, as the bionic ear manufacturer continues to expand globally.
Sales of the hearing devices have grow 26%, with almost half that from China.
Cochear will pay a fully franked $1.10 interim dividend, up from 90 cents.
The company expects full year profit to be between $180 million and $190 million, up from its previous forecast of $165 million and $175 million